Cargando…
Prediction of BRAF V600E variant from cancer gene expression data
BACKGROUND: BRAF inhibitors have been approved for the treatment of melanoma, non-small cell lung cancer, and colon cancer. Real-time polymerase chain reaction or next-generation sequencing were clinically used for BRAF variant detection to select who responds to BRAF inhibitors. The prediction of B...
Autores principales: | Kang, Jun, Lee, Jieun, Lee, Ahwon, Lee, Youn Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745377/ https://www.ncbi.nlm.nih.gov/pubmed/36523293 http://dx.doi.org/10.21037/tcr-22-883 |
Ejemplares similares
-
Prediction of homologous recombination deficiency from cancer gene expression data
por: Kang, Jun, et al.
Publicado: (2022) -
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013) -
Prediction of PIK3CA mutations from cancer gene expression data
por: Kang, Jun, et al.
Publicado: (2020) -
Predicting BRAF V600E variants: yet another new method
por: Natsumeda, Manabu
Publicado: (2022) -
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)